Business Process Management

PRODUCTS

  • MAVERICK product image
    Process Analytical Technology For In-line Bioprocess Analysis

    This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.

    All In-line Gain, No Modeling Pain

    MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.

  • GettyImages-1368931955 data
    Digital Transformation Services

    Enabling organizations of all sizes to transform their business through better use of technology.

  • ZS VSD+ oil-free screw blowers
    ZS (VSD+) Oil-Free Screw Blowers

    What is a rotary screw blower?
    Screw compressors delivering compressed air below 1.5 bar(g) are referred to as (rotary) screw blowers. The working principles of a screw blower are thus identical to those of a rotary screw compressor.

  • iMednet EDC
    Streamline Electronic Data Capture With iMednet EDC

    At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.

  • GettyImages-1339300422 CAR T-Cell Immunotherapy
    Immunotherapy Development

    Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.

WHITE PAPERS AND CASE STUDIES

NEWS